INTS vs LH · $7.7M cap vs P/E 23, rev $13.01B
Intensity Therapeutics, Inc. Common stock (INTS) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported LH revenue for 2024-12-31 was $13.01B. Net income was $747.1M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. LH currently screens at market cap $21.07B and trailing P/E 22.8.
INTS currently screens at market cap $7.7M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the INTS and LH stock pages for the full models.
Not investment advice.